Purpose
To assess the accuracy of triglyceride-glucose index (TyG) in the diagnosis of gestational diabetes mellitus (GDM).
Methods
Embase, Cochrane Library, PubMed, and Web of Science were searched up to April 18, 2025 for English-language clinical studies using TyG for GDM prediction. The Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) tool was utilized for quality assessment, and the final results were presented by RevMan5.3. The overall accuracy of TyG in GDM diagnosis was identified using Stata15.0 and Meta-DiSc1.4. We also performed subgroup analyses by the sample size, prevalence, cutoff, and trimester of pregnancy.
Results
Sixteen studies with 480,402 participants were included. The pooled sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio of TyG in GDM diagnosis were 0.63 (95 % CI 0.56–0.70), 0.64 (95 % CI 0.60–0.68), 1.80 (95 % CI 1.60–1.90), 0.57 (95 % CI 0.49–0.67), and 3.00 (95 % CI 2.00–4.00), respectively. The area under the summary receiver operating characteristic (SROC) curve of TyG was 0.68 (95 % CI 0.64–0.72). Subgroup analyses revealed that small sample sizes, high prevalence, cutoff < 8.5, and the second trimester corresponded to the high accuracy of TyG in GDM diagnosis.
Conclusion
TyG demonstrates moderate diagnostic accuracy for GDM, with an area under the SROC curve of 0.68. Considering the limitations of the available studies, more prospective studies are still required to clarify the diagnostic value of TyG in actual clinical practice and offer a stronger basis for clinical decision-making.
扫码关注我们
求助内容:
应助结果提醒方式:
